Results 71 to 80 of about 825 (170)

A Case of Blonanserin-Induced Mania in Schizophrenia

Korean Journal of Schizophrenia Research, 2012
Schizophrenia is a psychiatric disease which requires a long term treatment. Thus, patient’s therapeutic compliance can be very crucial to the disease’s prognosis. Moreover, the adverse effects of drugs are also important to determine the patient’s therapeutic compliance.
So-Young Park, Yong-Ku Kim, Jong-Ha Lee
openaire   +1 more source

Psychotic mania as the solitary manifestation of neurosyphilis

Annals of General Psychiatry, 2018
Background Neurosyphilis remains a diagnostic challenge in current psychiatric practice because of its pleomorphic psychiatric manifestations. Although neurosyphilis can present with a wide range of psychiatric symptoms, psychotic mania as its solitary ...
Eun Hyun Seo, Hae Jung Yang, Sang Hoon Kim, Jung Hyun Park, Hyung-Jun Yoon   +4 more
doaj   +1 more source

Effects of food and grapefruit juice on single-dosepharmacokinetics of blonanserin in healthy Chinese subjects

, 2018
Purpose The purpose of this study was to investigate the potentialeffects of a meal and grapefruit juice on the pharmacokineticsof blonanserin and its metabolite N-desethylblonanserin in healthy Chinese volunteers.Methods This was a single-centre, open ...
De-Wei Shang...[et al.]
core  

Behavioral and molecular effects of the antipsychotic drug blonanserin in the chronic mild stress model

, 2021
Psychiatric disorders represent a critical challenge to our society, given their high global prevalence, complex symptomatology, elusive etiology and the variable effectiveness of pharmacological therapies.
Lason, Magdalena, Begni, Veronica, Riva, Marco A, Gruca, Piotr, Litwa, Ewa, Marchisella, Francesca, Molteni, Raffaella, Guidi, Alice, Paladini, Maria Serena, Spero, Vittoria, Papp, Maurisz   +10 more
core   +1 more source

Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study

, 2020
Background: Blonanserin is a second-generation antipsychofic used for the treatment of schizophrenia.This study determined the efficacy, safety and pharmacokinetics of a blonanserin transdermal patch in patients with acutely exacerbated schizophrenia ...
Wang, Lina, Lin, Shih-Ku, Cosca, Rowena, Kane, John M., Correll, Christoph U., Higuchi, Teruhiko, Sato, Takayuki, Suchkov, Yury, Inoue, Yoshifumi, Agarkov, Alexey, Iwata, Nakao, Ishigooka, Jun, Kim, Won-Hyoung, Yoon, Bo-Hyun, Watabe, Kei, Matsui, Tomohito, Sulaiman, Ahmad Hatim   +16 more
core  

Effect of blonanserin on methamphetamine-induced disruption of latent inhibition and c-Fos expression in rats

, 2013
To clarify the psychopharmacological profile of blonanserin, a novel antipsychotic, we examined its effect on the methamphetamine-induced disruption of latent inhibition （LI） and the neural activation related to this effect in rats.
10404435, 小金丸, 剛, 池田, 哲也, Funahashi, Hideki, 8632, 船橋, 英樹, 倉増, 亜紀, Koganemaru, Go, マツオ, ヒサエ, イケダ, テツヤ, Nishimori , Toshikazu, 石田, 康, Ishida, Yasushi, ニシモリ, トシカズ, 8704, 武田, 龍一郎, 西森, 利數, フナハシ, ヒデキ, アベ, ヒロシ, Matsuo, Hisae, 24528, 20212897, タケダ, リュウイチロウ, 蛯原, 功介, 9050, 24524, 8383, 9110, Kuramashi, Aki, 安部, 博史, Ebihara, Kosuke, Abe, Hiroshi, 9053, 24525, 90336298, Ikeda, Tetsuya, イシダ, ヤスシ, 20112211, クラマシ, アキ, 24680, Takeda, Ryuichiro, エビハラ, コウスケ, コガネマル, ゴウ, 松尾, 寿栄   +43 more
core  

Effect of blonanserin on methamphetamine-induced disruption of latent inhibition and c-Fos expression in rats

To clarify the psychopharmacological profile of blonanserin, a novel antipsychotic, we examined its effect on the methamphetamine-induced disruption of latent inhibition （LI） and the neural activation related to this effect in rats.
小金丸, 剛, 池田, 哲也, Funahashi, Hideki, 船橋, 英樹, 倉増, 亜紀, Koganemaru, Go, マツオ, ヒサエ, イケダ, テツヤ, Nishimori , Toshikazu, 石田, 康, Ishida, Yasushi, ニシモリ, トシカズ, 武田, 龍一郎, 西森, 利數, フナハシ, ヒデキ, アベ, ヒロシ, Matsuo, Hisae, タケダ, リュウイチロウ, 蛯原, 功介, Kuramashi, Aki, 安部, 博史, Ebihara, Kosuke, Abe, Hiroshi, Ikeda, Tetsuya, イシダ, ヤスシ, クラマシ, アキ, Takeda, Ryuichiro, エビハラ, コウスケ, コガネマル, ゴウ, 松尾, 寿栄   +29 more
core   +1 more source

Guideline for pharmacological treatment of schizophrenia 2022

Neuropsychopharmacology Reports, Volume 45, Issue 1, March 2025.
Japanese Society of Neuropsychopharmacology, Japanese Society of Clinical Neuropsychopharmacology   +1 more
wiley   +1 more source

Characterization of binding of antipsychotics to muscarinic receptors using mouse cerebral cortex

Journal of Pharmacological Sciences, 2019
Antipsychotics are often the first-line treatment for behavioral and psychological symptoms of dementia. However, the potential anticholinergic effects of antipsychotics could counteract the therapeutic effects of cholinesterase inhibitors used to treat ...
Keisuke Obara, Saki Horiguchi, Toma Shimada, Takumi Ikarashi, Fumiko Yamaki, Kazuhiro Matsuo, Takashi Yoshio, Yoshio Tanaka   +7 more
doaj   +1 more source

Role of Blonanserin in Cannabis-induced Psychosis

European Psychiatry, 2015
Introduction Cannabis-induced psychosis is not uncommon and a lot of antipsychotics have been in use in clinical practice to address the problem. However, Blonanserin, a relatively new atypical antipsychotic has not yet been tested in cases like this. Objective and Aims This study aims to understand any possible role of Blonanserin in patients of ...
D. Pan, A. Mallick
openaire   +1 more source